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Abstract
Background & methods
The ICONIC project has developed an automated high-throughput pipeline to generate HIV
nearly full-length genomes (NFLG, i.e. from gag to nef) from next-generation sequencing
(NGS) data. The pipeline was applied to 420 HIV samples collected at University College
London Hospitals NHS Trust and Barts Health NHS Trust (London) and sequenced using an
Illumina MiSeq at the Wellcome Trust Sanger Institute (Cambridge). Consensus genomes
were generated and subtyped using COMET, and unique recombinants were studied with
jpHMM and SimPlot. Maximum-likelihood phylogenetic trees were constructed using RAxML
to identify transmission networks using the Cluster Picker.
Results
The pipeline generated sequences of at least 1Kb of length (median = 7.46Kb, IQR =
4.01Kb) for 375 out of the 420 samples (89%), with 174 (46.4%) being NFLG. A total of 365
sequences (169 of them NFLG) corresponded to unique subjects and were included in the
down-stream analyses. The most frequent HIV subtypes were B (n = 149, 40.8%) and C
(n = 77, 21.1%) and the circulating recombinant form CRF02_AG (n = 32, 8.8%). We found
14 different CRFs (n = 66, 18.1%) and multiple URFs (n = 32, 8.8%) that involved recombi-
nation between 12 different subtypes/CRFs. The most frequent URFs were B/CRF01_AE
(4 cases) and A1/D, B/C, and B/CRF02_AG (3 cases each). Most URFs (19/26, 73%)
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lacked breakpoints in the PR+RT pol region, rendering them undetectable if only that was
sequenced. Twelve (37.5%) of the URFs could have emerged within the UK, whereas the
rest were probably imported from sub-Saharan Africa, South East Asia and South America.
For 2 URFs we found highly similar pol sequences circulating in the UK. We detected 31
phylogenetic clusters using the full dataset: 25 pairs (mostly subtypes B and C), 4 triplets
and 2 quadruplets. Some of these were not consistent across different genes due to inter-
and intra-subtype recombination. Clusters involved 70 sequences, 19.2% of the dataset.
Conclusions
The initial analysis of genome sequences detected substantial hidden variability in the Lon-
don HIV epidemic. Analysing full genome sequences, as opposed to only PR+RT, identified
previously undetected recombinants. It provided a more reliable description of CRFs (that
would be otherwise misclassified) and transmission clusters.
Introduction
Human immunodeficiency virus type 1 (HIV-1) shows a great genetic diversity [1], which
causes the emergence of multiple viral strains. HIV-1 is classified in four groups: M, O, N and
P. HIV-1 group M drives the global pandemic, and includes 9 subtypes (A-D, F-H, J, K), at
least 88 circulating recombinant forms (CRFs) [2] and countless unique recombinant forms
(URFs), generated when cells are superinfected by HIV-1 virions from different subtypes/
CRFs. CRFs are defined as inter-subtype recombinant lineages that derived from the same
common ancestor, and for which at least three epidemiologically unlinked variants are mono-
phyletic and share an identical genetic structure along their full genome. URFs are recombi-
nants with different recombination breakpoints than those found in CRFs, and emerge after
localised, isolated recombination events. URFs are responsible for at least 20% of HIV-1 infec-
tions worldwide–a proportion that reaches 40% in some African countries [3].
HIV-1 subtype B is the prevalent variant in high-income areas like North America and
Western Europe [3], and the most studied strain despite only accounting for 12% of global
infections. However, in the last decade, the remaining subtypes and recombinants (“non-B
variants”, responsible for the remaining 88% of infections worldwide) have increased in preva-
lence and heterogeneity in developed countries [4]. The UK is no exception, and viral genetic
diversity (especially involving novel recombinants) markedly increased in the UK HIV-1 epi-
demic between 2002 and 2010 [5]. This new heterogeneity has resulted in the description of
an increasing number of CRFs in Western Europe, which traditionally were restricted to
regional hotspots with great co-circulation of variants–like sub-Saharan Africa, South-East
Asia and parts of South America. These new European recombinants include CRF47_BF and
CRF73_BG in Spain and Portugal [6, 7], CRF50_A1D in the UK [8], CRF56_cpx in France [9],
and CRF60_BC in Italy [10], as well as second-generation complex recombinant strains [11].
The genetic variability derived from the presence of non-B variants could affect manage-
ment of HIV-1 infection [12], including the antiretroviral response [13], the efficacy of viral
load and resistance assays [14], the speed of disease progression [15, 16], the emergence of
drug resistance mutations [17] and the vaccine development [18]. Additionally, HIV-1 recom-
bination is a powerful evolutionary force that occurs ten times more frequently than base sub-
stitutions [19] and produces and maintains further variability by shuffling and combining viral
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genetic material. HIV-1 recombination can accelerate the adaptation to the host [20], improve
viral replication [21] and provide mechanisms to escape both the immune response and antivi-
ral treatments [22–24]. At the same time, gene reshuffling derived by recombination can com-
pensate the loss in viral fitness derived from these adaptations [20] HIV will continue to evolve
and diversify, which will bring new challenges to prevention and treatment efforts.
Thus, the proper detection and description of HIV-1 variants in representative cohorts
is essential, especially considering the worldwide emergence and transmission of recombi-
nants. The coincidence of the increasing HIV-1 complexity in Western countries with the
rapid development of next-generation sequencing (NGS) technology [25] highlights the
potential of applying these techniques to routine surveillance of HIV-1 molecular epidemi-
ology. Here, we aimed to identify URFs in a dataset consisting on HIV-1 nearly full-
genome sequences obtained through NGS of samples taken in two major hospitals in Lon-
don, UK. We describe their recombination patterns using a combination of bioinformatics
tools, which include bootscanning and phylogenetic analysis of sequence sub-segments,
considered the reference methodology for detecting HIV-1 variants since its first use
[26, 27].
Methods
Pipeline and study subjects
Within the ICONIC project, we have developed an automated and customisable high-through-
put analysis pipeline to generate HIV clinical whole genomes, quantify minority variants and
identify drug-resistance mutations (DRMs). Via de novo assembly of contigs, concatenation
and correction by alignment to reference and subsequent remapping of reads, this pipeline
derives a consensus sequence and minority variants across each genome [28].
In order to generate HIV consensus genomes, the pipeline was applied to 420 HIV sam-
ples, collected between 2012 and 2014 at two major London clinics: University College Lon-
don Hospitals (UCLH) NHS Trust (n = 332) and Barts Health NHS Trust (n = 88). UCLH
NHS Trust specimens were from a cohort of 4,700 patients under follow-up in London of
which 75% of patients are men, 65% are men-having-sex-with-men (MSM) with a median
age of 44 years and 20% are over 50. Almost all (97%) were already on treatment and the
majority of tests (80%) were performed at virological failure or during treatment interrup-
tion pre restarting. Only 10–20% of specimens included baseline samples at diagnosis. Spec-
imens from Barts Health NHS Trust came from a cohort that includes 1,200 HIV genotypic
resistance tests each year from a North East London patient cohort. The catchment area
includes Barts Health NHS trust, the Homerton trust, and Barking, Havering and Redbridge
trust with a prevalence of HIV ranging from 1.6 to 7.4 per 1,000 adults. North-East Lon-
don’s population is diverse: Tower Hamlets and Hackney have large MSM populations and
Newham has the highest number of black Africans living with HIV in London. Most of the
patients in the cohort are men (64%), with a median age of 41 years and 22% aged over 50.
Approximately one fifth of samples tested are at baseline, the remainder tested because of
viral escape or non-compliance.
Viral RNA was extracted from plasma samples using a QIAamp Viral RNA Minikit (Qia-
gen). RNA extracted from plasma samples was reverse transcribed and amplified by one-step
RT-PCR using a set of 4 pan-HIV-1 primer set designed for the amplification of HIV-1
genomes of all groups and subtypes [25]. Amplicons were pooled for Illumina library prepara-
tion and sequenced applying next-generation sequencing on the Illumina MiSeq at the Well-
come Trust Sanger Institute (Cambridge) as previously described [29].
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Subtyping and recombination analyses
The consensus genomes were preliminary subtyped using a local implementation of COMET
version 1.1.4 [30], which included reference sequences of subtypes A1-H, J and K; CRFs 01–
29, 31–40, 42–47 and 49; and HIV-1 groups N, O and P. This method was applied to the full
dataset but also independently to the principal structural genes (gag, pol and env), extracted
using GeneCutter (https://www.hiv.lanl.gov/content/sequence/GENE_CUTTER/cutter.html).
This approach was followed in order to detect putative recombinant, i.e. those cases in which
different genes disagreed in subtype or any of them yielded an unassigned result. Those cases
were analyse in more depth using the jpHMM [31] online tool, which is capable of detecting
and locating recombination breakpoints in HIV-1 sequences.
In those sequences where these tools confirmed the presence of recombination events, fur-
ther analyses were applied using the program SimPlot version 3.5.1 [32], which applies a boot-
scanning method. This consists of a sliding-window phylogenetic bootstrap analysis of the
query sequence (using a window size of 300bp moving in 10bp increments) aligned against a
set of reference strains to reveal breakpoints, which was later confirmed by performing phylo-
genetic analysis using RAxML (GTR+Γ substitution model with 1000 bootstrap replicates) of
the inter-breakpoint segments. For these, we incorporated sequences from the 2010 HIV sub-
type reference alignment downloaded from Los Alamos National Laboratory HIV database
website [1].
In addition, to study the most likely geographical origin of the parental variants that gener-
ated the URF detected, we looked for genetically similar sequences from GenBank (retrieved
using HIV BLAST (https://www.hiv.lanl.gov/content/sequence/BASIC_BLAST/basic_blast.
html)) for each recombinant segment.
Finally, we extracted the ‘clinical’ PR+RT pol segment (covering the protease and the first
235 codons of the reverse transcriptase) of the URF sequences that presented breakpoints in
this coding region to retrospectively find highly genetically similar sequences within the UK
HIV Drug Resistance database (UKHDRD, http://www.hivrdb.org.uk/) through BLAST–these
sequences could represent recombinant lineages already circulating in the UK.
Analysis of intra-subtype recombination
Whereas inter-subtype recombination can be detected relatively easily, intra-subtype recombi-
nation is much more difficult to identify due to a greater sequence similarity between sequences
of the same subtype/variant, and the lack of standardised methodology. For the largest pure sub-
type datasets, we aimed to detect intra-subtype recombination using the program RDP version
4 [33] following the approach described by Kiwelu and colleagues [34]. In short, RDP4 uses 7
non-parametric recombination detection methods: RDP, GENECONV, modified Bootscan,
MAXCHI, CHIMAERA, SISCAN and 3SEQ. For each of these methods, the default RDP4 set-
tings were used. The recombination events considered definitive were those with statistically
significant support (p<0.05 after Bonferroni correction for multiple comparisons) for at least 3
out of the 5 algorithms. RDP4 screens all possible sequence triplets/quartets to find recombi-
nants and potential parents, which makes possible the analysis without reference sequences.
Analysis of phylogenetic clusters
In order to identify potential transmission clusters in the full dataset, we constructed maxi-
mum likelihood trees with RAxML (with the GTR+Γ substitution model) and applying the
Cluster Picker with a cutoff of 90% for node statistical support and6% for the intra-cluster
genetic diversity. In order to minimise the effect of recombination in the detection of clusters,
further Cluster Picker analyses of the genes gag (1.5Kb), pol (3Kb) and env (2.5Kb) were
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performed, using genetic diversity cutoffs of5.5%,4.5% and9%, respectively. These lev-
els were chosen taking as reference the value commonly used for pol [35] and adjusting the
rest of the genes according to their different evolutionary rates.
Ethics statement
The ICONIC project (IRAS project ID 131373) was approved by the NHS Research Ethics
Committee (13/LO/1303). ICONIC was also included in the Portfolio Database of the UK
Clinical Research Network (UKCRN ID: 15776). The ICONIC study does not require written
informed consent by study participants as it only uses pseudonymised residual diagnostic
material and no patient genetic material.
Results
Sequence dataset
The pipeline generated sequences of at least 1Kb of length (median = 7.46Kb, IQR = 4.01Kb)
for 375 out of the 420 ICONIC samples (89%), with 174 of the 375 (46.4%) sequences covering
the full ‘clinical’ genome (i.e. from gag to nef). The rest of sequences (n = 201) had variable
coverage.
The 375 assembled genomes were deposited in GenBank under the accession numbers
MF109352 to MF109726 (see Table A in S1 File). All the raw paired-end short reads were
deposited in the European Nucleotide Archive (ENA) under the study accession number
PRJEB6008. The Figure A in S1 File shows the alignment of the 375 sequences and the posi-
tions of the four primers used for amplification. Most of the sequence gaps corresponded to
amplification failure of the 2nd and 4th amplicons. An in-depth analysis of the impact of miss-
ing nucleotide characters in NGS sequence data generated with the same sequencing protocol
followed with the ICONIC samples has been previously published [36].
A linear regression analysis showed a statistically significant positive correlation between
the HIV-1 viral load and the sequence length (i.e., genomic coverage), yielding a correlation
value of R2 = 0.05 (p = 0.0026) (Figure B in S1 File).
Of the 375 sequences to be analysed, 365 corresponded to unique patients and were
included in the subsequent analyses.
HIV-1 subtype distribution
The HIV strains found were, ordered by frequency: subtype B (n = 149, 40.8%), subtype C
(n = 77, 21.1%), CRF02_AG (n = 32, 8.8%), subtype A1 (17, 4.7%),CRF01_AE (n = 15, 4.1%),
subtype G (10, 2.7%), CRF06_cpx (8, 2.2%), subtype D (7, 1.9%), subtype F1 (7, 1.9%) and 11
other CRFs (03_AB, 07_BC, 09_cpx, 13_cpx, 14_BG, 18_cpx, 19_cpx, 25_cpx, 43_02G, 49_cpx
and 60_BC) of which one case (0.3% each) was found. In total, we found 14 different CRFs
(n = 66, 18.1%). The remaining samples corresponded to multiple URFs (n = 32, 8.8%) that
involved recombination between 12 different parental variants: 7 subtypes (A1, B, C, D, F1, G
and J) and 5 CRFs (CRF01_AE, CRF02_AG, CRF06_cpx, CRF22_01A1 and CRF50_AD). The
most frequent URFs were B/CRF01_AE (4 cases) and A1/D, B/C, and B/CRF02_AG (3 cases
each). Their recombination patterns are shown in Figure C in S1 File.
Importantly, we generated new sequences of several CRFs that remain poorly (n<10) repre-
sented in public sequence databases, providing full-genome each of the following recombinants:
CRF03_AB (only 3 genome sequences available in GenBank), CRF13_cpx (8), CRF18_cpx (5),
CRF25_cpx (6) and CRF43_02G (4). Also, we provide partial genomes of CRF09_cpx, CRF19_cpx,
High HIV-1 strain variability in London, UK
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CRF49_cpx and CRF60_BC (one each), which will provide new and invaluable material for the
study of these recombinant lineages.
Subtype distribution using partial pol
In order to explore the implications of using only the PR+RT partial pol sequence to study the
HIV-1 subtype distribution, we extracted the 277 sequences (out of the total 365 sequence
dataset, 75.9%) that covered this region and applied the COMET and SCUEAL subtyping
tools. SCUEAL was used to make the results comparable to those from the UKHDRD reports
[5]. The prevalence of pure subtypes in the pol gene (74.4% for COMET and 73.0% for
SCUEAL) was similar to that found in the full-length ICONIC dataset (73.2%), with the only
exception of an overestimation of subtype G by SCUEAL (7.0% using pol versus 2.7% in the
definitive results; chi-square test p = 0.01). Differences found in the proportion of recombi-
nants (CRFs and/or URFs) were also not significant.
Focusing on the 32 URF sequences, 26 covered the 1.3Kb PR+RT pol region, of which only
7 (7/26, 26.9%) presented a breakpoint in that region and were consequently identified as
recombinants by both COMET and SCUEAL. The remaining 19 (19/26, 73%) URFs were
therefore mostly considered as pure subtypes/CRFs when only the PR+RT pol sequence was
analysed. As the PR+RT fragment represents only ~15% of the size of the genomes analysed
here, it is in fact detecting more recombinants than expected (26.9% versus 8.8% when analys-
ing the genome data; chi-square test p = 0.008).
Unique recombinant forms (URFs)
The 32 URF sequences were further explored by analysing the parental lineages that generated
them and their closest sequences in public sequence databases identified by BLAST. For those
URF presenting breakpoints in the PR+RT pol region, genetically similar pol sequences were
searched within the UK HIV Drug Resistance database (UKHDRD). In the following para-
graphs we provide a detailed explanation for the most frequent and/or complex URF. The rest
of the URF analyses are detailed in the Supporting Results in S1 File.
B/CRF50_A1D pair (accession numbers MF109354and MF109527, respectively). These
two URF_50B sequences that formed a phylogenetic pair (genome-wide similarity = 96.2%)
were classified as an A1/B/D recombinant by jpHMM, but after phylogenetic analysis of the
recombinant segments, those assigned to A1 and D clustered with the recombinant
CRF50_A1D (previously described in the UK [8]), and shared the same breakpoints between
A1 and D found in this CRF (Fig 1). Therefore, they were reclassified as B/CRF50_A1D. The
subtype B segment that covered the PR+RT region in pol presented high similarity (>98%) to
UK “pure” subtype B sequences in both the UKHDRD dataset and GenBank, which suggests
that these recombinants originated in the UK. A different URF_50B, presenting different
breakpoints as those reported here, was already described in Foster et al. [8] (see below for
more information on this recombinant sequence), suggesting that this CRF of Eastern African
origin is actively recombining with local sequences.
A1/B. Two URF_A1B were identified, with one of them (MF109544) presenting a long
gap between the A1 and B portions. The A1 segment was closest to sequences from Kenya
(similarity = 93%), whereas no close GenBank sequences to the subtype B portion could be
found. The other URF_A1B found (MF109371) presented a small A1 fragment in pol (694bp-
long) in a background of subtype B. Whereas the latter did not present high similarity close to
any GenBank sequence in gag or env, the A1 fragment was intimately related to CRF50_A1D
in the phylogenetic analysis, and particularly (similarity = 95%) to a B/CRF50_A1D recombi-
nant sequence (accession number JN417238, see above) also described in the article by Foster
High HIV-1 strain variability in London, UK
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Fig 1. A) Recombination pattern (according to jpHMM) of the two URF_50B (accession numbers MF109354 and MF109527) discovered in the ICONIC dataset and the
GenBank full-length sequence JN417236, prototype of the recombinant CRF50_A1D. B) Bootscanning analysis of the URF_50B performed using SimPlot and diagram
showing the definitive recombination pattern.
https://doi.org/10.1371/journal.pone.0192081.g001
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and colleagues [8] where this CRF is described. JN417238 and this newly described URF_A1B
shared common A1/B breakpoints in the PR+RT region although the latter presented addi-
tional breakpoints absent in the URF_A1B; however, they did not cluster together in their
common subtype B fragments. The PR+RT pol portion of both the URF_A1B described here
and, especially, of JN417238 were genetically similar (98%) to an A1/B cluster already
described in Canada that was identified through BLAST; we also found 5 GenBank A1/B
sequences sampled in the UK which were very similar. Within the UKHDRD, we identified 13
more PR+RT pol sequences circulating sharing breakpoints with this URF_A1B according to
jpHMM. These 13 UKHDRD sequences were mostly sampled on 2011–2012 but the oldest
one was sampled in 2006; and in all cases with available information, the patients had been
born in the UK. According to the ML tree (Fig 2), this A1/B lineage (and particularly
JN417238, the URF_50B previously described) initiated the Canadian cluster that affected
men-having-sex-with-men (MSM) population [37]. The clade also included 2 GenBank
sequences from Albania and Korea, respectively, which lied basal to the UK/Canadian cluster,
and points to a further international spread of this clade.
A1/D. We detected three URF_A1D sequences (MF109466, MF109548 and MF109564)
with different recombination patterns. In all cases, the closest sequences in GenBank were
sampled in Eastern Africa (Uganda, Kenya and/or Tanzania). Only one of them (MF109466)
presented a recombination breakpoint in the PR+RT pol region, for which through BLAST we
identified 27 pol sequences in the UKHDRD and 21 in GenBank (from Kenya, Uganda and
Tanzania, up to 96% of similarity) which showed a very similar A1/D breakpoint in the PR
+RT region. The 27 UKHDRD sequences corresponded exclusively to patients born in
Uganda, Kenya and Zimbabwe, and their samples were taken from 2001 to 2011. Both sets of
sequences sampled in the UK and GenBank sequences sampled in Eastern African countries
were interspersed in the tree (Fig 3) suggesting multiple introductions to the UK. One of the
GenBank sequences from Kericho, Kenya (accession number KT022394) had a full-length
sequence available which showed a recombination pattern that was very similar to that of this
URF_A1D across the genome in the overlapping regions, only different at the 3’ end of the env
gene. The presence of two sequence gaps in our sample prevented further exploration of the
relatedness of these 2 sequences.
CRF06_cpx/CRF22_01A1. We found 1 URF_0622 (MF109682) which was initially
identified as a recombinant between subtypes A1, G and J and CRF01_AE by jpHMM.
However, further analysis with SimPlot, which was confirmed by phylogenetic analysis of
the recombinant segments, revealed that segments ascribed to subtype J and G that partially
covered from vif to env actually corresponded to CRF06_cpx, and that the segments classi-
fied as A1 and CRF01_AE in gag, vif and nef clustered very closely to CRF22_A101 –a
recombinant lineage detected in Cameroon [38] (Fig 4). Unfortunately, this URF_0622
sequence lacked the PR+RT pol region, which prevented from identifying more cases of this
recombinant in the UKHDRD.
Fig 2. Panel A) Recombination pattern (according to jpHMM) of the URF_A1B (accession number MF109371) discovered in the ICONIC
dataset, the URF_50B full-length sequence (accession number KT022394) described by Foster and colleagues and a member of the A1/D
Canadian cluster described by Brenner and colleagues (accession number GU592197). These 3 which presented high similarity in the PR+RT
pol region. B) Maximum-likelihood tree of the PR+RT pol region (1,000bp) of the A1/B cluster of sequences with high similarity to the
ICONIC URF_A1B. Tips corresponding to the UKHRD are in orange. Tip names show, for the GenBank sequences: subtype, sampling
country, accession number and sampling year (not available for the Canadian sequences); for UKHDRD sequences: country of birth, ID and
sampling year. Branches corresponding to the A1/B cluster are shown in blue. The ICONIC URF_A1B sequence is highlighted with an arrow.
The tree is rooted to subtype A1 reference sequences. The diagram at the right shows the recombination pattern shown by the sequences in
the cluster, according to jpHMM.
https://doi.org/10.1371/journal.pone.0192081.g002
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CRF02_AG/CRF06_cpx (MF109687). This URF presented segments of subtypes A1, G,
C and J that corresponded in ML trees and SimPlot to the recombinant CRF06_cpx (which is
made up by subtypes A1, C, G and J). Interestingly, subtype A1 fragments in this URF clus-
tered within CRF02_AG and not CRF06_cpx (Fig 5). In fragments in which both CRFs corre-
spond to subtype G (in this case, the beginning of pol and env genes) the presence of further
breakpoints cannot be ruled out. Recombinants between CRF02_AG and CRF06_cpx have
already been discovered in Western Europe [39] probably introduced from Western Africa, a
region where both CRF frequently co-circulate. Indeed, the closest GenBank sequences to this
URF’s PR+RT pol region were “pure” CRF06_cpx sequences from Mali, Burkina Faso and Sen-
egal (96%).
Intra-subtype recombination
We analysed the largest ‘pure’ subtype datasets (i.e. subtypes B and C with 149 and 77
sequences, respectively) for evidence of intra-subtype recombination using RDP4. A sequence
was considered an intra-subtype recombinant if the recombination signal was statistically sig-
nificantly supported by at least 3 of the methods implemented in RDP4. We found 20 subtype
B sequences (13.4%) that were identified as recombinants with enough statistical support. For
subtype C, 7 sequences (9.1%) were intra-subtype recombinants. This difference was not statis-
tically significant.
Analysis of phylogenetic clusters
We detected 31 phylogenetic clusters using the full sequence dataset. Of them, 25 were pairs
(corresponding mostly to subtypes B (n = 11) and C (n = 4)), 4 were triplets (1 each for A1, B,
F1, and CRF06_cpx) and 2 quadruplets (CRF02_AG and CRF06_cpx). These clusters involved
70 sequences, 23.5% of the dataset. In order to explore the consistence of these clusters across
different genes, we also examined clusters analysing the main HIV-1 genes independently: gag,
pol and env. Seventeen (54.8%) of the 31 clusters detected in the full dataset were also found in
the individual analyses of gag, pol and env. Their intra-subtype maximum genetic distance and
bootstrap support values for each gene is shown in the Table B in S1 File. The average genetic
distance across the 17 clusters was 2.06% for the genome-wide analysis (range: 0.08–5.27%),
1.75% (0–5.19%) for gag, 1.33% (0.03–2.96%) for pol and 3.05% (0–8.92%) for env.
Most of the inter-gene cluster disagreements (6/14, 43%) were due to the fact that not all
sequences in a given cluster completely covered the 3 genes. In 4 (29%) cases the sequences
were too divergent (above the genetic distance cutoff) in one of the genes: gag and pol in 2
cases (genetic distances of 6.0–7.6%), gag alone (7.9%) in one case, env alone (12.9%) in the
last one. The last disagreement (7%) was due to the fact that the statistical support of the node
was below the cutoff (boostrap = 88%) in the gag gene tree. Finally, there were 3 cases (21%) in
which certain sequences showed entirely different tree topologies according to the gene ana-
lysed. One of them involved a phylogenetic pair of pure F1 sequences that clustered very
closely with a URF_02BF1 (MF109637, whose recombination pattern is described in Support-
ing Results in S1 File and shown in Figure C in S1 File) only in the gag gene, which suggests
Fig 3. Panel A) Recombination pattern (according to jpHMM) of the URF_A1D (accession number MF109466) discovered in the ICONIC
dataset and the GenBank full-length A1/D sequence KT022394, which presented high similarity in the PR+RT pol region. B) Maximum-
likelihood tree of the PR+RT pol region (1,000bp) of the A1/D cluster of sequences with high similarity to the ICONIC URF_A1D. Tips
corresponding to the UKHRD are in orange. Tip names show, for the GenBank sequences: subtype, sampling country, accession number
and sampling year; for UKHDRD sequences: country of birth, ID and sampling year. Branches corresponding to the A1/D cluster are shown
in blue. The ICONIC URF_A1D and the GenBank sequence KT022394 are highlighted with arrows. The tree is rooted to a subtype B
sequence. The diagram at the right shows the recombination pattern shown by the sequences in the cluster, according to jpHMM.
https://doi.org/10.1371/journal.pone.0192081.g003
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that the former could represent the parental lineage involved in the generation of that URF.
The other 2 cases of phylogenetic inconsistence corresponded to subtype B clusters in which
presumably, as the RDP analysis suggested, intra-subtype recombination had modified their
clustering pattern.
Conclusions
The analysis of HIV-1 nearly full-genome sequences generated by the ICONIC project
detected substantial variability in the London HIV-1 epidemic. The HIV-1 subtype distribu-
tion in our dataset is generally consistent with that reported in the last update (corresponding
to 2010) for the whole UK based on analysis of pol sequences [5]. The main difference lies on
the prevalence of CRFs, which was 6.2% in that report in contrast to the 18.1% (3-fold higher)
presented here. We demonstrate here how using the pol sequence alone, in this case using
SCUEAL as Dolling and colleagues did, underestimated the proportion of CRFs–other subtyp-
ing tools, such as COMET, will face other limitations depending on the exact subtyping algo-
rithm. This highlights that analysis of nearly full-genome sequences is key to identifying
already established recombinant lineages. In addition, CRF lineages that are traditionally very
infrequent in Western countries but were identified in the present study (e.g. CRF19_cpx,
CRF49_cpx, CRF43_02G and CRF60_BC) are generally absent in the reference sequence data-
sets that are used by automatised HIV-1 subtyping tools.
Conversely, the use of longer sequences allowed for a more refined description of novel
recombinants (URFs), since the accuracy on their detection using pol sequences relies on the
presence of breakpoints within this short (~1Kb) genomic region. The 32 URFs that were
detected using the full dataset involved recombination between 12 different parental strains,
and some of them presented a very complex recombination pattern. Interestingly, 18 (56%) of
the URF contained segments corresponding subtype B, the prevalent variant in Western coun-
tries. Four of these URFs (URF_01B) could have been introduced from South East Asia, where
many similar recombinants have been described, and another 2 (a URF_BF1 transmission
pair) from South America, where B/F1 recombinants represent a substantial proportion of the
HIV-1 infections [3]. However, the remaining 12 URFs involving subtype B probably emerged
in the UK (or at least in Western Europe) after introduction of non-subtype B variants which
recombined with the local subtype B. The rest of the URFs (n = 14, 44%) were recombinant
between HIV-1 variants that co-circulate in sub-Saharan Africa, so they could have been gen-
erated before been introduced to the UK. Some of them were particularly complex, and
implied further recombination between recombinant lineages (the so-called “second-genera-
tion” recombinants), a phenomenon already detected among African migrants in Western
Europe [11, 39].
Matching the ICONIC sequences to the PR+RT pol sequences stored in the UK Drug Resis-
tance Database allowed us to uncover new lineages of unique recombinants already circulating
in the UK. Specifically, we detected an A1/B recombinant lineage circulating among UK-born
patients whose oldest sequence was sampled in 2006. Another example was a larger A1/D
clade that mostly involved patients born in Uganda and Kenya and sampled as far back as
2001, but also included many sequences from GenBank sampled in those Eastern African
countries–which might indicate several introductions in the UK as opposed to local spread
from a single one.
Fig 4. A) Recombination pattern (according to jpHMM) of the URF_0622 (accession number MF109682) discovered in the ICONIC dataset and the
sequences AF064699 and EU743963, prototypes of the recombinants CRF06_cpx and CRF22_01A1, respectively. B) Bootscanning analysis of the
URF_0106G performed using SimPlot and diagram showing the definitive recombination pattern.
https://doi.org/10.1371/journal.pone.0192081.g004
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Unfortunately, we did not have patient epidemiological data available for these samples to
confirm whether subjects infected by URFs came from areas with co-circulation of HIV-1
strains or were infected in the UK. However, the HIV-infected population attended in the clin-
ics included in the study mainly corresponded to men-having-sex-with-men (MSM), who tra-
ditionally have been mostly infected in the UK (e.g. 68% of MSM in 2015 [40]).
The analysis of phylogenetic clusters did not identify large HIV-1 transmission networks,
but the largest ones discovered here corresponded to recombinant variants (2 quadruplets of
CRF02_AG and CRF06_cpx respectively). We found disagreements between clusters detected
using different viral genes (i.e. gag, pol and env) that in some cases highlight the fact that
recombination can obscure the genetic relationships between sequences belonging to the same
transmission network. This also evidences the lack of standardisation in the cluster definition
when analysing genes other than pol, and that will be needed with the increasing generation of
full-genome datasets. In an attempt to help developing genetic distance cutoffs, we provide in
Table B in S1 File the values found for the clusters that were consistent across genes.
Recombination between different subtypes/CRFs happens frequently and its detection is
relatively straightforward. However, the detection of recombinants between different virions
of a same subtype is much more challenging due to their lower genetic diversity, and therefore
remains understudied. We applied the methodology used by Kiwelu and colleagues [34] to the
largest pure subtype datasets in ICONIC (subtypes B and C) and found similar intra-subtype
recombination frequencies in subtypes B (13.4%) and C (9.1%).
Unfortunately, the low availability of HIV-1 full genomes in public databases prevented
deeper exploration of the linkage between our dataset and non-UK epidemics, and also to pro-
vide more insights into the evolutionary history of the unique recombinants described here.
Another limitation was the fact that not all our sequences were full-length genomes due to an
unequal efficacy of the sequencing primers. In addition, although the study of HIV-1 strain
distribution can provide valuable insights due to the different biological properties of certain
subtypes, the growing heterogeneity of the viral epidemics will challenge the current HIV-1
strain classification.
In conclusion, the use of nearly full-genome sequences, as opposed to only PR+RT, pro-
vided a more reliable description of CRFs (that would be otherwise misclassified) and permit-
ted the detection of novel recombinants circulating in London. Whereas it is likely that some
of the URFs were imported from abroad, our work suggests that a large proportion of them
could have been generated locally.
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